Lorrain D S, Matuszewich L, Friedman R D, Hull E M
Department of Psychology, State University of New York at Buffalo, Buffalo, New York 14260, USA.
J Neurosci. 1997 Dec 1;17(23):9361-6. doi: 10.1523/JNEUROSCI.17-23-09361.1997.
Serotonin (5-HT) is generally inhibitory to masculine sexual behavior. It has been suggested that 5-HT released after ejaculation may promote the sexual quiescence of the postejaculatory interval (PEI). The following experiments were conducted to test (1) whether extracellular 5-HT increases in either the anterior lateral hypothalamic area (LHAA) or the medial preoptic area (MPOA) of male rats after ejaculation; (2) whether increasing 5-HT in these sites, by microinjecting the selective serotonin reuptake inhibitor alaproclate, could inhibit copulatory abilities; and (3) whether copulation deficits produced by alaproclate were attributable to locomotor impairments. The effects of local application of alaproclate on extracellular 5-HT levels in the LHAA and the MPOA were also tested. Extracellular serotonin was measured in all experiments using in vivo microdialysis. Ejaculation was correlated with enhanced 5-HT release from the LHAA; no 5-HT increases were observed before ejaculation, and levels were decreased toward basal values during a subsequent copulatory series. Elevating 5-HT in the LHAA by microinjecting alaproclate inhibited copulation by increasing the latency to mount, intromit, and ejaculate. This inhibition did not result from nonspecific locomotor impairments. In the MPOA, 5-HT release remained stable throughout copulation, and microinjecting alaproclate into this site did not significantly alter sexual behavior. These data support the large body of evidence suggesting that 5-HT is inhibitory to masculine sexual behavior. Furthermore, the LHAA, but not the MPOA, may be one site responsible for serotonergic inhibition of copulation during the PEI.
血清素(5-羟色胺,5-HT)通常对雄性性行为具有抑制作用。有人提出,射精后释放的5-HT可能会促进射精后间隔期(PEI)的性静止。进行了以下实验来测试:(1)雄性大鼠射精后,下丘脑前外侧区(LHAA)或内侧视前区(MPOA)的细胞外5-HT是否增加;(2)通过微量注射选择性5-羟色胺再摄取抑制剂阿普氯铵来增加这些部位的5-HT,是否会抑制交配能力;(3)阿普氯铵导致的交配缺陷是否归因于运动障碍。还测试了局部应用阿普氯铵对LHAA和MPOA中细胞外5-HT水平的影响。在所有实验中,均使用体内微透析法测量细胞外血清素。射精与LHAA中5-HT释放增强相关;射精前未观察到5-HT增加,且在随后的交配过程中其水平降至基础值。通过微量注射阿普氯铵提高LHAA中的5-HT会增加爬上、插入和射精的潜伏期,从而抑制交配。这种抑制并非由非特异性运动障碍引起。在MPOA中,整个交配过程中5-HT释放保持稳定,向该部位微量注射阿普氯铵并未显著改变性行为。这些数据支持了大量表明5-HT对雄性性行为具有抑制作用的证据。此外,LHAA而非MPOA可能是PEI期间5-羟色胺能抑制交配的一个部位。